Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Liver Diseases

Free Subscription 15.04.2019 2 AJR Am J Roentgenol 4 Anticancer Res 1 BMC Cancer 4 Dig Dis Sci 2 Gut 7 Hepatology 1 Indian J Gastroenterol 2 Int J Cancer 1 J Gastroenterol Hepatol 4 J Hepatol 1 J Pediatr 6 Lancet Gastroenterol Hepatol 1 Lancet Haematol 5 Lancet Oncol 1 N Engl J Med 8 PLoS One 1 Semin Liver Dis

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. SMITH AD, Porter KK, Elkassem AA, Sanyal R, et al
   Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis.
   AJR Am J Roentgenol. 2019 Apr 11:1-13. doi: 10.2214/AJR.19.21144.
   PubMed     Text format     Abstract available
   
   
2. WALSER EM
   Lollipops.
   AJR Am J Roentgenol. 2018;210:W182.
   PubMed     Text format    
   
   

   
   Anticancer Res

3. YAMADA M, Yamamoto Y, Sugiura T, Kakuda Y, et al
   Comparison of the Clinicopathological Features in Small Bile Duct and Bile Ductular Type Intrahepatic Cholangiocarcinoma.
   Anticancer Res. 2019;39:2121-2127.
   PubMed     Text format     Abstract available
   
   
4. MIYATA T, Beppu T, Imamura YU, Hayashi H, et al
   A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
   Anticancer Res. 2019;39:2139-2144.
   PubMed     Text format     Abstract available
   
   
5. NAGAI H, Mukozu T, Kobayashi K, Amanuma M, et al
   Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by Etiology.
   Anticancer Res. 2019;39:2183-2191.
   PubMed     Text format     Abstract available
   
   
6. KIM SS, Eun JW, Cho HJ, Lee HY, et al
   Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma.
   Anticancer Res. 2019;39:2217-2226.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

7. BUISMAN FE, Homs MYV, Grunhagen DJ, Filipe WF, et al
   Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
   BMC Cancer. 2019;19:327.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

8. JOPSON L, Khanna A, Peterson P, Rudell E, et al
   Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.
   Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5074.
   PubMed     Text format     Abstract available
   
   
9. LENHART A, Hussain S, Salgia R
   Chances of Renal Recovery or Liver Transplantation After Hospitalization for Alcoholic Liver Disease Requiring Dialysis.
   Dig Dis Sci. 2018 Jun 22. pii: 10.1007/s10620-018-5170.
   PubMed     Text format     Abstract available
   
   
10. SHETTY A, Hsu JW, Manka PP, Syn WK, et al
    Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018;63:3187-3206.
    PubMed     Text format     Abstract available
    
    
11. CHASCSA DM, Lai JC, Dunn MA, Montano-Loza AJ, et al
    Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5271.
    PubMed     Text format     Abstract available
    
    

    
    Gut

12. SCOAZEC JY
    Hepatocellular adenomas: one step beyond.
    Gut. 2019 Apr 9. pii: gutjnl-2019-318299. doi: 10.1136/gutjnl-2019-318299.
    PubMed     Text format    
    
    
13. CHE L, Chi W, Qiao Y, Zhang J, et al
    Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
    Gut. 2019 Apr 6. pii: gutjnl-2018-317581. doi: 10.1136/gutjnl-2018-317581.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

14. LI N, Wei L, Liu X, Bai H, et al
    A frizzled-like cysteine rich domain in glypican-3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30646.
    PubMed     Text format     Abstract available
    
    
15. CHIU V, Hogen R, Sher L, Wade N, et al
    Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30557.
    PubMed     Text format     Abstract available
    
    
16. HE Y, Hwang S, Cai Y, Kim SJ, et al
    MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30645.
    PubMed     Text format     Abstract available
    
    
17. TRIVEDI HD, Lau DTY, Kulai TB, Malhi H, et al
    Hepatology Highlights.
    Hepatology. 2019;69:1849-1851.
    PubMed     Text format    
    
    
18. CHEN YJ, Tsai CF, Wang YP, Lu CL, et al
    To the editor: Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics.
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30641.
    PubMed     Text format     Abstract available
    
    
19. DHANASEKARAN R, Felsher DW
    A Tale of Two Complications of Obesity: Nonalcoholic steatohepatitis (NASH) and Hepatocellular carcinoma (HCC).
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30649.
    PubMed     Text format     Abstract available
    
    
20. DESROCHES-CASTAN A, Tillet E, Ricard N, Ouarne M, et al
    BMP9 is a paracrine factor controlling liver sinusoidal endothelial cell fenestration and protecting from hepatic fibrosis.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30655.
    PubMed     Text format     Abstract available
    
    

    
    Indian J Gastroenterol

21. SHAH D, Makharia GK, Ghoshal UC, Varma S, et al
    Burden of gastrointestinal and liver diseases in India, 1990-2016.
    Indian J Gastroenterol. 2018;37:439-445.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

22. YANG P, Huang X, Lai C, Li L, et al
    SET domain containing 1B gene (SETD1B) is mutated in primary hepatic neuroendocrine tumors.
    Int J Cancer. 2019 Apr 11. doi: 10.1002/ijc.32334.
    PubMed     Text format     Abstract available
    
    
23. GE Z, Feng Y, Sheh A, Muthupalani S, et al
    Mutagenicity of Helicobacter hepaticus infection in the lower bowel mucosa of 129/SvEv Rag2(-/-) Il10(-/-) gpt delta mice is influenced by sex.
    Int J Cancer. 2019 Apr 11. doi: 10.1002/ijc.32332.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

24. WATSON H, Guevara M, Vilstrup H, Gines P, et al
    Improvement of hyponatremia in cirrhosis is associated with improved complex information processing.
    J Gastroenterol Hepatol. 2019 Apr 9. doi: 10.1111/jgh.14683.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

25. GERARD C, Di-Luoffo M, Gonay L, Caruso S, et al
    Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma.
    J Hepatol. 2019 Apr 3. pii: S0168-8278(19)30195.
    PubMed     Text format     Abstract available
    
    
26. CABIBBO G, Celsa C, Calvaruso V, Petta S, et al
    Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
    J Hepatol. 2019 Apr 5. pii: S0168-8278(19)30221.
    PubMed     Text format     Abstract available
    
    
27. WANDELER G, Mauron E, Atkinson A, Dufour JF, et al
    Incidence of Hepatocellular Carcinoma in HIV/HBV-coinfected Patients on Tenofovir therapy: Relevance for Screening Strategies.
    J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30226.
    PubMed     Text format     Abstract available
    
    
28. OVEREEM AW, Klappe K, Parisi S, Kloters-Planchy P, et al
    Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity.
    J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30225.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr

29. FANNA M, Rougemont AL, Arni D, Toso C, et al
    Giant Intrahepatic Lipoblastoma in a Child.
    J Pediatr. 2019 Apr 4. pii: S0022-3476(19)30272.
    PubMed     Text format    
    
    

    
    Lancet Gastroenterol Hepatol

30. THOMAS T, Chandan JS, Bhala N
    Unmet needs in end-of-life care for chronic liver disease.
    Lancet Gastroenterol Hepatol. 2019;4:6-7.
    PubMed     Text format    
    
    
31. SANDUZZI-ZAMPARELLI M, Forner A
    Systemic doxorubicin and hepatocellular carcinoma: the end of an era never risen up.
    Lancet Gastroenterol Hepatol. 2019 Apr 3. pii: S2468-1253(19)30091.
    PubMed     Text format    
    
    
32. MERLE P, Blanc JF, Phelip JM, Pelletier G, et al
    Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2019 Apr 3. pii: S2468-1253(19)30040.
    PubMed     Text format     Abstract available
    
    
33. 
    Correction to Lancet Gastroenterol Hepatol 2019; 4: 135-84.
    Lancet Gastroenterol Hepatol. 2019;4:e4.
    PubMed     Text format    
    
    
34. TSENG TC, Shih YF, Liu CJ
    A simple non-invasive test for ruling out cirrhosis in chronic hepatitis B.
    Lancet Gastroenterol Hepatol. 2019 Apr 8. pii: S2468-1253(19)30118.
    PubMed     Text format    
    
    
35. SONNEVELD MJ, Brouwer WP, Chan HL, Piratvisuth T, et al
    Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study.
    Lancet Gastroenterol Hepatol. 2019 Apr 8. pii: S2468-1253(19)30087.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Haematol

36. KANDA Y
    Is pharmacokinetic guidance a must in busulfan regimens?
    Lancet Haematol. 2018;5:e498-e499.
    PubMed     Text format    
    
    

    
    Lancet Oncol

37. KATZENSTEIN HM, Langham MR, Malogolowkin MH, Krailo MD, et al
    Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Lancet Oncol. 2019 Apr 8. pii: S1470-2045(18)30895.
    PubMed     Text format     Abstract available
    
    
38. DAS M
    TACE plus external beam radiotherapy in liver cancer.
    Lancet Oncol. 2018;19:e231.
    PubMed     Text format    
    
    
39. RANSCOMBE P
    Don't let the data cloud the image.
    Lancet Oncol. 2018;19:736.
    PubMed     Text format    
    
    
40. HAEMMERICH D
    Non-invasive image-guided targeted drug delivery.
    Lancet Oncol. 2018;19:1000-1001.
    PubMed     Text format    
    
    
41. CZAUDERNA P
    Is it worth completely resecting hepatoblastoma at diagnosis?
    Lancet Oncol. 2019 Apr 8. pii: S1470-2045(19)30096.
    PubMed     Text format    
    
    

    
    N Engl J Med

42. VILLANUEVA A
    Hepatocellular Carcinoma.
    N Engl J Med. 2019;380:1450-1462.
    PubMed     Text format    
    
    

    
    PLoS One

43. LIEN HC, Jeng YM, Jhuang YL, Yuan RH, et al
    Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.
    PLoS One. 2018;13:e0206261.
    PubMed     Text format     Abstract available
    
    
44. BONKOVSKY HL, Barnhart HX, Foureau DM, Steuerwald N, et al
    Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
    PLoS One. 2018;13:e0206389.
    PubMed     Text format     Abstract available
    
    
45. CHANG E, Kim DH, Yang H, Lee DH, et al
    CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.
    PLoS One. 2018;13:e0206152.
    PubMed     Text format     Abstract available
    
    
46. XIONG Y, Zhang Q, Ye J, Pan S, et al
    Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    PLoS One. 2018;13:e0206853.
    PubMed     Text format     Abstract available
    
    
47. ADAMS LC, Lubbe F, Bressem K, Wagner M, et al
    Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.
    PLoS One. 2018;13:e0206450.
    PubMed     Text format     Abstract available
    
    
48. KIM EJ, Chung DH, Kim YJ, Kim YS, et al
    Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.
    PLoS One. 2018;13:e0206694.
    PubMed     Text format     Abstract available
    
    
49. CHIANG HC, Chien YC, Lin PY, Lee HL, et al
    Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings.
    PLoS One. 2018;13:e0206438.
    PubMed     Text format     Abstract available
    
    
50. VAN DER WAALS LM, Borel Rinkes IHM, Kranenburg O
    ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    PLoS One. 2018;13:e0205536.
    PubMed     Text format     Abstract available
    
    

    
    Semin Liver Dis

51. WEINBERG EM, Palecki J, Reddy KR
    Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
    Semin Liver Dis. 2019 Apr 12. doi: 10.1055/s-0039-1679934.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: